Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease

OBJECTIVE: To observe the effect on total liver volume (TLV) on and off therapy in selected symptomatic patients with autosomal dominant polycystic kidney disease (ADPKD) or autosomal dominant polycystic liver disease (PLD) who received octreotide long-acting release (OctLAR) for up to 4 years. PATI...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mayo Clin Proc
Huvudupphovsmän: Hogan, Marie C., Masyuk, Tetyana, Bergstralh, Eric, Li, Bill, Kremers, Walter K., Vaughan, Lisa E., Ihrke, Angela, Severson, Amanda L., Irazabal, Maria V., Glockner, James, LaRusso, Nicholas F., Torres, Vicente E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928579/
https://ncbi.nlm.nih.gov/pubmed/26166166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2015.05.011
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk